Personalized Medicine | 2014(11) articles
- A possible future for the pharmaceutical industry
- Association of matrix metalloproteinase-7A-181G variants with the risk of multiple sclerosis
- Personalizing care for nonalcoholic fatty liver disease patients: what are the research priorities?
- Past, current and future approaches to querying MAPK pathway activation: status and clinical implications
- Molecular profiling and companion diagnostics: where is personalized medicine in cancer heading?